Danaher Corporation $DHR Shares Sold by Triglav Investments D.O.O.

Triglav Investments D.O.O. lessened its stake in shares of Danaher Corporation (NYSE:DHR) by 67.9% in the 1st quarter, HoldingsChannel reports. The institutional investor owned 6,000 shares of the conglomerate’s stock after selling 12,700 shares during the quarter. Triglav Investments D.O.O.’s holdings in Danaher were worth $1,138,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in DHR. Elevated Capital Advisors LLC acquired a new position in shares of Danaher in the 4th quarter worth approximately $26,000. Hilton Head Capital Partners LLC acquired a new stake in Danaher in the 4th quarter valued at approximately $27,000. Clal Insurance Enterprises Holdings Ltd increased its holdings in Danaher by 71.6% in the 4th quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate’s stock valued at $29,000 after purchasing an additional 53 shares during the last quarter. JPL Wealth Management LLC purchased a new stake in Danaher in the third quarter valued at approximately $25,000. Finally, WFA of San Diego LLC acquired a new position in Danaher during the second quarter worth $26,000. 79.05% of the stock is owned by hedge funds and other institutional investors.

Danaher Trading Up 0.0%

NYSE:DHR opened at $199.11 on Monday. Danaher Corporation has a 12-month low of $160.93 and a 12-month high of $242.80. The firm has a market cap of $140.92 billion, a PE ratio of 38.51, a price-to-earnings-growth ratio of 2.54 and a beta of 0.79. The company has a current ratio of 1.87, a quick ratio of 1.52 and a debt-to-equity ratio of 0.33. The stock has a fifty day moving average price of $180.59 and a 200 day moving average price of $199.27.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Monday, April 20th. The conglomerate reported $2.06 earnings per share for the quarter, topping the consensus estimate of $1.94 by $0.12. The company had revenue of $5.95 billion for the quarter, compared to the consensus estimate of $6 billion. Danaher had a return on equity of 10.91% and a net margin of 14.89%.Danaher’s revenue was up 3.7% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.88 EPS. Sell-side analysts anticipate that Danaher Corporation will post 8.44 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be paid a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date is Friday, June 26th. Danaher’s dividend payout ratio is presently 30.95%.

Wall Street Analyst Weigh In

Several research firms have recently commented on DHR. The Goldman Sachs Group lowered their price target on Danaher from $265.00 to $230.00 and set a “buy” rating for the company in a research report on Monday, April 13th. Morgan Stanley decreased their target price on Danaher from $270.00 to $255.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 22nd. Wall Street Zen cut Danaher from a “buy” rating to a “hold” rating in a report on Saturday, April 25th. DZ Bank started coverage on Danaher in a research report on Wednesday, June 3rd. They issued a “buy” rating and a $210.00 target price for the company. Finally, Robert W. Baird cut their price target on shares of Danaher from $251.00 to $249.00 and set an “outperform” rating on the stock in a research note on Friday, April 17th. One investment analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating, four have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $231.64.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.